Summit Therapeutics CFO resigns; COO Manmeet Soni appointed new CFO

Summit Therapeutics Inc.

CFO Ankur Dhingra resigned April 2, 2024, not due to any disagreement with the company.
COO Manmeet Soni appointed CFO in addition to his COO role; receives $100K cash bonus and 1,100,000 options vesting over 4 years.
Bhaskar Anand hired as Chief Accounting Officer, Head of Finance; salary $430K, 40% bonus, 1,200,000 options (half performance-based).
New CFO Manmeet Soni previously CFO at Reata and Alnylam; both Soni and Anand are CPAs and Chartered Accountants.
Anand previously served as CAO at Reata and assisted with a $7.5B merger with Biogen.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Bhaskar Anand

Chief Accounting Officer, Head of Finance

SMMT · Summit Therapeutics Inc.

Effective: 2024-04-02
Filed: April 3, 2024, 7:59 PM ET

On April 2, 2024, the Company hired Bhaskar Anand as Chief Accounting Officer, Head of Finance, to serve as its principal accounting officer.

Departed

Ankur Dhingra

Chief Financial Officer

SMMT · Summit Therapeutics Inc.

Effective: 2024-04-02
Successor: Manmeet Soni
Filed: April 3, 2024, 7:59 PM ET

On April 2, 2024, Ankur Dhingra, the principal financial officer and principal accounting officer of Summit Therapeutics Inc. (the “Company”), resigned as Chief Financial Officer of the Company.

Appointed

Manmeet Soni

Chief Financial Officer

SMMT · Summit Therapeutics Inc.

Effective: 2024-04-02
Filed: April 3, 2024, 7:59 PM ET

the Company appointed its Chief Operating Officer Manmeet Soni to the office of Chief Financial Officer, in which capacity he will serve as the Company’s principal financial officer, in addition to his continuing service as Chief Operating Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Bhaskar Anand was appointed as Chief Accounting Officer, Head of Finance at Summit Therapeutics Inc..

Action: hired
Role: Chief Accounting Officer, Head of Finance

Exact text from the filing

On April 2, 2024, the Company hired Bhaskar Anand as Chief Accounting Officer, Head of Finance, to serve as its principal accounting officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Ankur Dhingra resigned as Chief Financial Officer at Summit Therapeutics Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On April 2, 2024, Ankur Dhingra, the principal financial officer and principal accounting officer of Summit Therapeutics Inc. (the “Company”), resigned as Chief Financial Officer of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Manmeet Soni was appointed as Chief Financial Officer at Summit Therapeutics Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

the Company appointed its Chief Operating Officer Manmeet Soni to the office of Chief Financial Officer, in which capacity he will serve as the Company’s principal financial officer, in addition to his continuing service as Chief Operating Officer.

View on SEC.gov

Summit Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001599298-24-000051

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.